BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wall G, Herrera N, Lopez-Ribot JL. Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box. J Fungi (Basel) 2019;5:E92. [PMID: 31581540 DOI: 10.3390/jof5040092] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Rollin-Pinheiro R, Almeida YC, Rochetti VP, Xisto MIDDS, Borba-Santos LP, Rozental S, Barreto-Bergter E. Miltefosine Against Scedosporium and Lomentospora Species: Antifungal Activity and Its Effects on Fungal Cells. Front Cell Infect Microbiol 2021;11:698662. [PMID: 34368017 DOI: 10.3389/fcimb.2021.698662] [Reference Citation Analysis]
2 Billamboz M, Fatima Z, Hameed S, Jawhara S. Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris. Microorganisms 2021;9:634. [PMID: 33803604 DOI: 10.3390/microorganisms9030634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Barreto TL, Rossato L, de Freitas ALD, Meis JF, Lopes LB, Colombo AL, Ishida K. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris. Int J Antimicrob Agents 2020;56:106049. [PMID: 32544569 DOI: 10.1016/j.ijantimicag.2020.106049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
4 Meis JF, Chowdhary A. Candida auris-"Ten Years After". J Fungi (Basel) 2019;6:E2. [PMID: 31861308 DOI: 10.3390/jof6010002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Vazquez-Munoz R, Lopez FD, Lopez-Ribot JL. Bismuth Nanoantibiotics Display Anticandidal Activity and Disrupt the Biofilm and Cell Morphology of the Emergent Pathogenic Yeast Candida auris. Antibiotics (Basel) 2020;9:E461. [PMID: 32751405 DOI: 10.3390/antibiotics9080461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Vazquez-Munoz R, Dongari-Bagtzoglou A. Anticandidal Activities by Lactobacillus Species: An Update on Mechanisms of Action. Front Oral Health 2021;2:689382. [PMID: 35048033 DOI: 10.3389/froh.2021.689382] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Frías-De-León MG, Hernández-Castro R, Vite-Garín T, Arenas R, Bonifaz A, Castañón-Olivares L, Acosta-Altamirano G, Martínez-Herrera E. Antifungal Resistance in Candida auris: Molecular Determinants. Antibiotics (Basel) 2020;9:E568. [PMID: 32887362 DOI: 10.3390/antibiotics9090568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Borba-Santos LP, Vila T, Rozental S. Identification of two potential inhibitors of Sporothrix brasiliensis and Sporothrix schenckii in the Pathogen Box collection. PLoS One 2020;15:e0240658. [PMID: 33052959 DOI: 10.1371/journal.pone.0240658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nelson BN, Beakley SG, Posey S, Conn B, Maritz E, Seshu J, Wozniak KL. Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans. Sci Rep 2021;11:13619. [PMID: 34193926 DOI: 10.1038/s41598-021-92991-6] [Reference Citation Analysis]
10 Wall G, Lopez-Ribot JL. Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics (Basel) 2020;9:E445. [PMID: 32722455 DOI: 10.3390/antibiotics9080445] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
11 Lim W, Verbon A, van de Sande W. Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach. Expert Opin Drug Discov 2022. [PMID: 35612364 DOI: 10.1080/17460441.2022.2080195] [Reference Citation Analysis]
12 Beattie SR, Krysan DJ. Antifungal drug screening: thinking outside the box to identify novel antifungal scaffolds. Curr Opin Microbiol 2020;57:1-6. [PMID: 32339892 DOI: 10.1016/j.mib.2020.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Wall G, Lopez-Ribot JL. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity. Antimicrob Agents Chemother 2020;64:e00924-20. [PMID: 32660991 DOI: 10.1128/AAC.00924-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kim JH, Cheng LW, Chan KL, Tam CC, Mahoney N, Friedman M, Shilman MM, Land KM. Antifungal Drug Repurposing. Antibiotics (Basel) 2020;9:E812. [PMID: 33203147 DOI: 10.3390/antibiotics9110812] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Coelho RA, Joffe LS, Alves GM, Figueiredo-Carvalho MHG, Brito-Santos F, Amaral ACF, Rodrigues ML, Almeida-Paes R. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis. PLoS One 2020;15:e0229630. [PMID: 32401759 DOI: 10.1371/journal.pone.0229630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Jampilek J. Novel avenues for identification of new antifungal drugs and current challenges. Expert Opin Drug Discov 2022. [PMID: 35787715 DOI: 10.1080/17460441.2022.2097659] [Reference Citation Analysis]
17 Wall G, Chen E, Hull MV, Lopez-Ribot JL. Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation. Front Cell Infect Microbiol 2020;10:597931. [PMID: 33324579 DOI: 10.3389/fcimb.2020.597931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Dos Reis TF, Horta MAC, Colabardini AC, Fernandes CM, Silva LP, Bastos RW, Fonseca MVL, Wang F, Martins C, Rodrigues ML, Silva Pereira C, Del Poeta M, Wong KH, Goldman GH. Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine. mBio 2021;12:e0145821. [PMID: 34372704 DOI: 10.1128/mBio.01458-21] [Reference Citation Analysis]
19 de Moraes DC. Current scenario of the search for new antifungal agents to treat Candida auris infections: An integrative review. J Mycol Med 2021;32:101232. [PMID: 34883404 DOI: 10.1016/j.mycmed.2021.101232] [Reference Citation Analysis]
20 Rollin-Pinheiro R, Borba-Santos LP, da Silva Xisto MID, de Castro-Almeida Y, Rochetti VP, Rozental S, Barreto-Bergter E. Identification of Promising Antifungal Drugs against Scedosporium and Lomentospora Species after Screening of Pathogen Box Library. J Fungi (Basel) 2021;7:803. [PMID: 34682224 DOI: 10.3390/jof7100803] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bidaud A, Djenontin E, Botterel F, Chowdhary A, Dannaoui E. Colistin interacts synergistically with echinocandins against Candida auris. International Journal of Antimicrobial Agents 2020;55:105901. [DOI: 10.1016/j.ijantimicag.2020.105901] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]